<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48541">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01844128</url>
  </required_header>
  <id_info>
    <org_study_id>0257-12mmc</org_study_id>
    <nct_id>NCT01844128</nct_id>
  </id_info>
  <brief_title>The Effect of Weight Loss on Ovarian Reserve</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity affects on fertility. Obese women have lower pregnancy rate after infertility
      treatments.They need more doses of hormone during ovarian stimulation, more days for
      stimulation. During IVF treatment less oocytes are collected and the quality of embryo also
      harmed.

      The first line treatment for those women with obesity and infertility is weight loss.

      The investigators' hypothesis is that weight reduction improves ovarian reserve and
      fertility treatment outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators have outpatient clinic for obesity and infertility. the patients
      undergoing program of 3 months with diet and physical activity. Blood sample will take at
      the beginning of the program and at the end. The blood sample will evaluate for: AMH,
      Adiponectin, Leptin, CRP, Colesterol, CRP, Smac in addition TVUS will perform to evaluate
      AFC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Anti Mullerain Hormone (AMH)and AFC before and after weight loss</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>AMH and AFC will measure at the first visit and after 3 months of weight loss program</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Weight Loss</condition>
  <arm_group>
    <arm_group_label>overweight women with infertility</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>weight loss</intervention_name>
    <arm_group_label>overweight women with infertility</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Overweight women with infertility
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing weight loss program

        Exclusion Criteria:

          -  dropp out before comletion the weighy loss target
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amir Wiswe, MD</last_name>
    <phone>+97297472227</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar Sava</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Overweight &amp;Infertility clinic</last_name>
      <phone>097471555</phone>
    </contact>
    <investigator>
      <last_name>Amir Wiser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>June 10, 2013</lastchanged_date>
  <firstreceived_date>April 28, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>Amir Wiser</investigator_full_name>
    <investigator_title>Senior physician IVF Unit</investigator_title>
  </responsible_party>
  <keyword>MMA, AFC, Ovarian reserve</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
